Actemra and Triamcinolone drug interactions - a phase IV clinical study of FDA data
Drug interactions are reported among 540 people who take Actemra and Triamcinolone. Common interactions include oedema among females, and drug ineffective among males.
The phase IV clinical study analyzes what interactions people who take Actemra and Triamcinolone have. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
540 people who take Actemra and Triamcinolone together, and have interactions are studied.
What is Actemra?
Actemra has active ingredients of tocilizumab. It is used in rheumatoid arthritis. Currently, eHealthMe is studying from 97,639 Actemra users.
What is Triamcinolone?
Triamcinolone has active ingredients of triamcinolone. Currently, eHealthMe is studying from 21,445 Triamcinolone users.
Number of Actemra and Triamcinolone reports submitted per year:
Actemra and Triamcinolone drug interactions by gender *:
Actemra and Triamcinolone drug interactions by age *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Actemra and Triamcinolone?Personalize this study to your gender and age
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Drug side effects by duration, gender and age:
Common Actemra drug interactions:
- Actemra and Methotrexate: 55,684 reports
- Actemra and Enbrel: 39,076 reports
- Actemra and Orencia: 38,141 reports
- Actemra and Humira: 36,292 reports
- Actemra and Prednisone: 33,780 reports
- Actemra and Arava: 26,672 reports
- Actemra and Sulfasalazine: 26,117 reports
- Actemra and Remicade: 25,360 reports
- Actemra and Xeljanz: 23,749 reports
- Actemra and Leflunomide: 23,225 reports
Browse interactions between Actemra and drugs from A to Z:a b c d e f g h i j k l m n o p q r s t u v w x y z
Common Triamcinolone drug interactions:
- Triamcinolone and Prednisone: 3,561 reports
- Triamcinolone and Aspirin: 2,956 reports
- Triamcinolone and Omeprazole: 2,479 reports
- Triamcinolone and Gabapentin: 2,449 reports
- Triamcinolone and Vitamin d: 1,937 reports
- Triamcinolone and Lisinopril: 1,875 reports
- Triamcinolone and Furosemide: 1,847 reports
- Triamcinolone and Albuterol: 1,823 reports
- Triamcinolone and Dupixent: 1,813 reports
- Triamcinolone and Tramadol: 1,674 reports
Browse interactions between Triamcinolone and drugs from A to Z:a b c d e f g h i j k l m n o p q r s t u v w x y z
How the study uses the data?
The study uses data from the FDA. It is based on tocilizumab and triamcinolone (the active ingredients of Actemra and Triamcinolone, respectively), and Actemra and Triamcinolone (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Actemra and Triamcinolone.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Methylphenidate Hydrochloride and Loratadine drug interaction - a second ago
- Oxycodone and Azathioprine Sodium drug interaction - 2 seconds ago
- Triatec and Hypokalemia - 6 seconds ago
- Alphagan P and Allopurinol drug interaction - 11 seconds ago
- Glimepiride and Polymyalgia Rheumatica - 11 seconds ago
- Zemplar and Maxalt drug interaction - 12 seconds ago
- Flagyl and Sorafenib drug interaction - 18 seconds ago
- Adcal and Drug Ineffective - 19 seconds ago
- Copegus and Cough Aggravated - 22 seconds ago
- Isoniazid and Capoten drug interaction - 25 seconds ago